DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Recombinate (Antihemophilic Factor) - Current Clinical Trials

 
 



Recombinate Related Clinical Trials

Study to Establish Bioequivalence of ReFacto AF (BDDrFVIII) With Advate (FLrFVIII) in Hemophilia A [Completed]

Assessment of the Risk of Inhibitor Formation in Previously Treated Patients With Severe Hemophilia A [Terminated]

Dose-Response Study of Recombinant Factor VIII Manufactured Protein-Free (rAHF-PFM) in Patients With Hemophilia A [Active, not recruiting]

Study Evaluating Safety Of Patients Switching To ReFacto AF In Usual Care Settings [Recruiting]

Study Comparing Blood Levels of ReFacto and Advante in Hemophilia A [Completed]

Study of Safety And Efficacy Of ReFacto AF In Previously Untreated Hemophilia A Patients In The Usual Care Setting. [Recruiting]

Study Evaluating Safety And Efficacy Of Moroctocog Alfa (AF-CC) In Previously Treated Hemophilia A Patients [Recruiting]

Pharmacokinetics and Safety of a Single Intravenous Infusion of BAY 79-4980 [Completed]

Study of Safety and Efficacy of Antihemophilic Factor/Von Willebrand Factor Complex in Surgical Subjects With Von Willebrand Disease (vWD) [Completed]

Study Evaluating Prophylaxis Treatment & Characterizing Efficacy, Safety, & PK Of B-Domain Deleted Recombinant FVIII [Recruiting]

Efficacy and Safety Study of a Recombinant Protein-Free Manufactured Factor VIII (rAHF-PFM) in Previously Untreated Hemophilia A Patients [Active, not recruiting]

EffeKt Taiwan- Efficacy and Safety of Long-term Treatment With KOGENATE® FS in Taiwan [Recruiting]

Survey of Inhibitors in Plasma-Product Exposed Toddlers [Recruiting]

An Open-label Safety, Efficacy and Pharmacokinetic Study of a Recombinant FVIII Compared to Recombinant Human Antihemophilic FVIII in Patients With Severe Hemophilia A [Recruiting]

EFFEKT - Efficacy and Safety of Long-term Treatment With KOGENATE Bayer/FS [Recruiting]

Kogenate FS Regulatory Post-Marketing Surveillance [Recruiting]

PEGylated rFVIII (BAX 855) in Hemophilia A [Not yet recruiting]

Study Evaluating On-Demand Treatment of Xyntha in Chinese Subjects [Recruiting]

Pharmacokinetic Comparison of Advate rAHF-PFM With Recombinate rAHF in Patients With Severe Hemophilia A [Recruiting]

Study Evaluating Pharmacovigilance Of Refacto AF [Recruiting]

Effekt-2 - Efficacy and Safety of Long-term Treatment With KOGENATE® FS in Latin America [Recruiting]

Study of the Efficacy of Human Recombinant Factor VIII (Kogenate FS) Reconstituted in Pegylated Liposomes. [Completed]

Pharmacokinetic Study of ADVATE 3000 IU in Previously Treated Patients With Severe Hemophilia A [Recruiting]

Comparison of the Action of Drugs in the Body and Safety of N8 and Advate® in Haemophilia A Subjects [Not yet recruiting]

Study Evaluating BDDRFVIII and ReFacto AF in Hemophilia A [Completed]

Study Evaluating B-Domain Deleted Recombinant Factor VIII (BDDrFVIII, ReFacto AF) in Patients With Hemophilia A Undergoing Elective Major Surgery [Recruiting]

Hemophilia Adult Prophylaxis Study [Recruiting]

Trial to Evaluate the Effect of Secondary Prophylaxis With rFVIII Therapy in Severe Hemophilia A Adult and/or Adolescent Subjects Compared to That of Episodic Treatment. (SPINART) [Recruiting]

Non-interventional Observation of Practical Implementation, Efficacy and Safety of Continuous Infusion With KOGENATE Bayer in Surgery [Recruiting]

A Canadian Study to Assess the Safety of Humate-P® Ivr (Infusion Volume Reduced) [Recruiting]

Early Prophylaxis Immunologic Challenge (EPIC) Study [Recruiting]

Phase 3/4 Study of a Recombinant Protein-Free Factor VIII (rAHF-PFM): Comparison of Continuous Infusion Versus Intermittent Bolus Infusion in Hemophilia A Subjects Undergoing Major Orthopedic Surgery [Recruiting]

Study Evaluating ReFacto® in Hemophilia A Undergoing Major Surgery [Completed]

Russian Kogenate Pediatric Study [Recruiting]

Prophylaxis Study of Recombinant Factor VIII Manufactured Protein-Free (rAHF-PFM) in Patients With Hemophilia A [Recruiting]

Pharmacokinetics, Safety and Efficacy of Recombinant Von Willebrand Factor (rVWF) in the Treatment of Bleeding Episodes in Von Willebrand Disease (VWD) [Recruiting]

Pharmacokinetic, Safety and Tolerability Study of Recombinant Von Willebrand Factor / Recombinant Factor VIII Complex in Type 3 Von Willebrand Disease [Recruiting]

Efficacy and Safety Study of a Recombinant and Protein-Free Factor VIII (rAHF-PFM) in Pediatric Patients in Canada With Hemophilia A - A Continuation of Baxter Study 060101 [Completed]

Safety Study of Alphanate in Previously Treated Patients With Severe Hemophilia A [Recruiting]

Trial of Rituximab Versus Oral Cyclophosphamide to Eradicate or Suppress Autoimmune Anti-Factor VIII Antibodies in Acquired Hemophilia A [Recruiting]

Safety and Efficacy of Recombinant Factor VIII (N8) in Male Children Previously Treated With Haemophilia A [Recruiting]

Clot Formation and Clot Stability in Patients With Severe Haemophilia A [Completed]

ADVATE Post Authorization Safety Surveillance [Completed]

Trial to Evaluate the Efficacy and Safety of a New Full Length Recombinant Human FVIII for Hemophilia A [Recruiting]

Study Evaluating Refacto for Pharmacovigilance [Recruiting]

Study Evaluating the Efficacy and Safety of Xyntha™ in Children Less Than 6 Years of Age [Not yet recruiting]

Validation Study of a cOmputer Pharmacokinetic Tool to assIst in the Follow up Care of haeMophilia A Patients [Recruiting]

Pharmacokinetics, Efficacy and Safety Study of IMMUNATE SD (Human Plasma-Derived Coagulation Factor VIII Concentrate) in Hemophilia A Patients [Completed]

BAY14-2222 Continuous Infusion in Surgeries [Completed]

Efficacy and Safety Study of Prophylactic Versus On-Demand Treatment With Feiba NF in Subjects With Hemophilia A or B and a High Titer Inhibitor [Recruiting]

Study of Pharmacokinetics, Efficacy, and Safety of a Recombinant and Protein-Free Factor VIII (rAHF-PFM) in Pediatric Patients With Hemophilia A [Completed]

Severe Pregnancy Complications Are Associated With Elevated Factor VIII Plasma Activity [Active, not recruiting]

Study to Evaluate the Safety, Pharmacokinetics and Efficacy of Recombinant Factor VIII Fc Fusion Protein (rFVIIIFc) in Subjects With Severe Hemophilia A [Recruiting]

Study of Recombinant Coagulation Factor VIII Fc Fusion Protein, BIIB 031, in Pediatric PTP Subjects With Hemophilia A [Recruiting]

Genetic Susceptibility to Factor VIII Inhibitors [Recruiting]

Kogenate Liplong Study - BAY 79-4980 Compared to rFVIII-FS in Previously Treated Patients With Severe Hemophilia A [Recruiting]

Study Evaluating ReFacto AF in Severe Hemophilia A [Completed]

Effect of Recombinant FVIII in Healthy Male Subjects Treated With TB-402 [Recruiting]

Study Evaluating ReFacto in Hemophilia A [Completed]

Study of Modified Recombinant Factor VIII (OBI-1) in Subjects With Acquired Hemophilia A [Recruiting]

Once-A-Day Prophylaxis for Youth and Young Adults With Severe Hemophilia A [Recruiting]

Safety and Efficacy Study of a Recombinant and Protein-Free Factor VIII (rAHF-PFM) in Hemophilia A Patients Undergoing Surgery [Completed]

Study of First TIME Immunotolerance Induction in Severe Hemophilia A Patients With Inhibitor at High Risk of Failure: Comparison With FVIII Concentrates With or Without Von Willebrand Factor - RES.I.S.T. Naive [Recruiting]

Study of Pharmacokinetics, Efficacy and Safety of a Recombinant and Protein-Free Factor VIII (rAHF-PFM) in Hemophilia A Patients – A Continuation of Clinical Study 069901 [Completed]

Study of Recombinant Porcine Factor VIII (FVIII) in Hemophilia and Inhibitors to FVIII [Completed]

Safety and Efficacy of N8 in Haemophilia A Subjects [Recruiting]

Evaluation of the Reasons and Consequences of Bleeding in Late Teens and Early Adulthood Patients With Severe Hemophilia A [Recruiting]

Study Evaluating Inhibitor Specificity in Hemophilia A [Terminated]

A Study With OPTIVATE® in People With Von Willebrand Disease [Recruiting]

Recombinant Factor VIIa (NovoSeven) on Restoring Coagulation Activation [Completed]

Covalent Tolerance Induction to Factor VIII-Prediction of Inhibitors in Hemophilia [Recruiting]

Rituximab to Treat Severe Hemophilia A [Recruiting]

Combination Therapy of Low Doses of rFVIIa and FEIBA for Severe Hemophilia A Patients With an Inhibitor to Factor VIII [Active, not recruiting]

International Immune Tolerance Study [Recruiting]

Efficacy of Alphanate FVIII/VWF Concentrate in Type 3 Von Willebrand Patients [Recruiting]

Cooperative Study of Factor VIII Inhibitors [Completed]

Effect of Indinavir Plus Two Other Anti-HIV Drugs on Blood Clotting in HIV-Positive Males With Hemophilia [Completed]

Observational Patient Diary Study of Treatment Doses for Patients With Haemophilia With Inhibitors to Factors VIII and IX [Recruiting]

Optivate in People With Von Willebrand Disease Undergoing Surgery [Recruiting]

Investigate Impact of Yasmin vs Microgynon on Hemostasis Parameters in Healthy Women [Completed]

Study Evaluating the Safety of Moroctocog Alfa (AF-CC) in Usual Care Settings [Not yet recruiting]

BAY14-2222 Prophylaxis and Joint Function Improvement (Adults) [Active, not recruiting]

A Phase I Study of Monoclonal Antibody TB-402 in Healthy Male Volunteers [Completed]

Effects of LMWH in Healthy Subjects Treated With TB-402 and Effects of TB-402 in Healthy Subjects Treated With Warfarin [Recruiting]

Intravitreal Bevacizumab for Proliferative Diabetic Retinopathy

Prospective Clinical and Biological Follow-up of Acquired Haemophilia : SACHA Study

Observational Study on the Efficacy and Safety of NovoSeven® During "Real-Life" Usage in Germany [Recruiting]

Birth Control Pill vs Birth Control Patch Study [Completed]

Platelet Function And Aggregometry In Patients With Aortic Valve Stenosis [Recruiting]

Almond Dose Response Study. [Completed]

Risk Factors for Developing a Blood Clot in Patients Who Are Undergoing Cancer Treatment for Newly Diagnosed Gliomas [Recruiting]

Dose Effects of Hormone Therapy (Two Doses of Estradiol Associated to Progesterone) on Inflammatory Markers [Terminated]

The Effect of the Mini-Pill on Blood Factors in Women at Increased Risk for Forming Blood Clots [Recruiting]

Musculoskeletal Function in Hemophilia [Active, not recruiting]

The Effect of a Levonorgestrel-releasing Intrauterine Device (IUD) Versus a Copper Containing IUD on Risk of Blood Clots [Recruiting]

Hemostatic Effect of Various Colloid Solutions [Recruiting]

The Von Willebrand Disease (VWD) International Prophylaxis (VIP) Study [Recruiting]

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2012